Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Zongertinib |
Trade Name | |
Synonyms | BI-1810631|BI1810631|BI 1810631 |
Drug Descriptions |
Zongertinib is an ERBB2 (HER2) selective inhibitor with potential anti-tumor activity (J of Clin Oncol 40, no. 16_suppl (June 01, 2022) TPS9143, PMID: 36528522). |
DrugClasses | HER2 Inhibitor 42 |
CAS Registry Number | 2728667-27-2 |
NCIT ID | C189906 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Adagrasib + Zongertinib | Adagrasib Zongertinib | 0 | 0 |
Ado-trastuzumab emtansine + Zongertinib | Ado-trastuzumab emtansine Zongertinib | 0 | 1 |
Trastuzumab deruxtecan + Zongertinib | Trastuzumab deruxtecan Zongertinib | 0 | 1 |
Zongertinib | Zongertinib | 0 | 3 |